Dominika Rudnicka-Noulin, PhD, MSc is a Business Insights Analyst in the Cardiovascular, Metabolic and Renal division at Decision Resources Group.
Prior to joining DRG, Dominika held a position of an Associate Editor at Nature Communications, working across a variety of therapy areas.
Dominika also worked for three years as a Postdoctoral Research Associate on a joint project between Imperial College London and MedImmune aimed at developing more potent antibody-based drugs.
Dominika gained her PhD from the Institut Pasteur in Paris, France. Her work there was funded by the European Commission Marie Skłodowska-Curie Actions.